{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:47:18Z","timestamp":1791920838823,"version":"4.3.4"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Cryptococcal meningitis (CM) is a leading cause of adult meningitis in countries with a high burden of HIV. It has remained a significant cause of morbidity and mortality in Africa despite the extensive rollout of HIV antiretroviral therapy (ART). This study aimed to systematically synthesize the evidence on the prevalence of CM among people living with HIV (PLWH) and its predictors of mortality among adults who are on induction antifungal therapy in Africa.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>PubMed\/MEDLINE, Embase, and Google Scholar were searched for randomized clinical trials or observational studies published in Africa from 1995 to April 2021. Pooled prevalence of CM among PLWH was calculated using R-studio Version 1.4.1717 software and the data extracted from eligible studies were pooled as percentage with a 95% confidence interval (CI). Predictors of mortality among adults on induction antifungal therapy were synthesized narratively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Out of 364 studies identified, 17 eligible articles were included in the analysis. The prevalence of CM among PLWH in Africa was 5.11% (95% CI 2.71\u20139.43%; participants = 10,813; studies = 9; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> = 97%). In the subgroup analysis, the prevalence was 12.9% (95% CI 4.883\u201330.0; participants = 533; studies = 3; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> = 63%) in the years 1995\u20132010 and 3.18% (95% CI 1.54\u20136.45; participants = 10,280; studies = 6; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> = 98%) in the years 2011\u20132021, with the prevalence significantly decreased by 51% (<jats:italic>p<\/jats:italic> = <jats:italic>0.02<\/jats:italic>). Predictors of mortality were fluconazole monotherapy, focal neurological signs, low Glasgow coma scale, and delayed diagnosis of CM at varied timepoint.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Prevalence of CM has significantly decreased from 1996\u20132010 to 2011\u20132021 among PLWH on induction therapy in Africa. Fluconazole monotherapy, focal neurological symptoms, diastolic blood pressure &amp;lt; 60 mmHg, and concurrent tuberculosis coinfection were significant predictors of mortality at 2- and 10-weeks timepoints. CM remains a major concern among PLWH despite increases in ART coverage. Improved access to effective antifungal therapies is needed in Africa for timely initiation of combination induction therapy and better treatment outcomes of PLWH.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p>[<jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=254113<\/jats:ext-link>], identifier [CRD42021254113].<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.989265","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T11:29:41Z","timestamp":1662636581000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Prevalence of cryptococcal meningitis among people living with human immuno-deficiency virus and predictors of mortality in adults on induction therapy in Africa: A systematic review and meta-analysis"],"prefix":"10.3389","volume":"9","author":[{"given":"Seke G. Y.","family":"Muzazu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawit Getachew","family":"Assefa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christabel","family":"Phiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tewodros","family":"Getinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samrawit","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizachew","family":"Yismaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsegahun","family":"Manyazewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163036","article-title":"The epidemiology of meningitis among adults in a South African province with a high HIV prevalence, 2009-2012.","volume":"11","author":"Britz","year":"2016","journal-title":"PLoS One."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005575","article-title":"Cryptococcal meningitis: a neglected NTD?","volume":"11","author":"Molloy","year":"2017","journal-title":"PLoS Negl Trop Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect Dis."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy267","article-title":"High mortality in HIV-Associated cryptococcal meningitis patients treated with amphotericin B-Based Therapy Under Routine Care Conditions in Africa.","volume":"5","author":"Patel","year":"2018","journal-title":"Open Forum Infect Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e831","DOI":"10.1016\/S2352-3018(19)30196-1","article-title":"Global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017.","volume":"6","year":"2019","journal-title":"Lancet HIV."},{"key":"B6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s42770-020-00383-1","article-title":"Cryptococcal meningitis in non-HIV patients in the State of Amazonas, Northern Brazil.","volume":"52","author":"Pinheiro","year":"2020","journal-title":"Braz J Microbiol."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1177\/2049936120940881","article-title":"Increased cryptococcal meningitis mortality among HIV negative, non-transplant patients: a single US center cohort study.","volume":"7","author":"Motoa","year":"2020","journal-title":"Ther Adv Infect Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/S0140-6736(15)60164-7","article-title":"Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial.","volume":"385","author":"Mfinanga","year":"2015","journal-title":"Lancet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/QCO.0000000000000514","article-title":"Emerging concepts in HIV-associated cryptococcal meningitis.","volume":"32","author":"Lawrence","year":"2019","journal-title":"Curr Opin Infect Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"212","DOI":"10.4103\/0377-4929.41689","article-title":"Prevalence of HIV-associated cryptococcal meningitis and utility of microbiological determinants for its diagnosis in a tertiary care center.","volume":"51","author":"Thakur","year":"2008","journal-title":"Indian J Pathol Microbiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1097\/QAD.0b013e3282a4a64d","article-title":"HIV-associated cryptococcal meningitis.","volume":"21","author":"Jarvis","year":"2007","journal-title":"Aids."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05510-9","article-title":"Triple therapy combined with ventriculoperitoneal shunts can improve neurological function and shorten hospitalization time in non-HIV cryptococcal meningitis patients with increased intracranial pressure.","volume":"20","author":"Li","year":"2020","journal-title":"BMC Infect Dis."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.17673.1","article-title":"Recent advances in managing HIV-associated cryptococcal meningitis.","volume":"8","author":"Boyer-Chammard","year":"2019","journal-title":"F1000Research."},{"key":"B14","first-page":"p. 1","year":"2018","journal-title":"Guidelines for the diagnosis prevention and management of cryptococcal disease in hiv-infected adults adolescents and children."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.ED000130","article-title":"Updating guidance for preventing and treating cryptococcal disease in low and middle income countries: how evidence and decisions interface.","volume":"30","author":"Migone","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ijid.2020.02.057","article-title":"Time to embrace access programmes for medicines: lessons from the South African flucytosine access programme.","volume":"95","author":"Shroufi","year":"2020","journal-title":"Int J Infect Dis."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004865","article-title":"Prevalence and hospital management of amphotericin b deoxycholate-related toxicities during treatment of HIV-associated cryptococcal meningitis in South Africa.","volume":"10","author":"Meiring","year":"2016","journal-title":"PLoS Negl Trop Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/liv.14364","article-title":"Can we cure hepatitis B virus with novel direct-acting antivirals?","author":"Martinez","year":"2020","journal-title":"Liver Int."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-6405-9-11","article-title":"The pattern and predictors of mortality of HIV\/AIDS patients with neurologic manifestation in Ethiopia: a retrospective study.","volume":"9","author":"Berhe","year":"2012","journal-title":"AIDS Res Ther."},{"key":"B20","first-page":"56","article-title":"Clinical outcomes of cryptococcal meningitis among HIV-infected patients in the era of antiretroviral therapy.","volume":"48","author":"Kobayashi","year":"2017","journal-title":"Southeast Asian J Trop Med Public Health."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-2126-6","article-title":"Comparison of clinical features and prognostic factors in HIV-negative adults with cryptococcal meningitis and tuberculous meningitis: a retrospective study.","volume":"17","author":"Qu","year":"2017","journal-title":"BMC Infect Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/qjmed\/93.4.245","article-title":"Cryptococcal meningitis in non-HIV-infected patients.","volume":"93","author":"Shih","year":"2000","journal-title":"QJM."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-4798-1","article-title":"Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100\u2013200 cells\/mm 3.","volume":"20","author":"Wykowski","year":"2020","journal-title":"BMC Infect Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/hiv.12387","article-title":"Prognostic implications of baseline anaemia and changes in haemoglobin concentrations with amphotericin B therapy for cryptococcal meningitis.","volume":"18","author":"Tugume","year":"2017","journal-title":"HIV Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/cid\/ciz454","article-title":"One-year mortality outcomes from the advancing cryptococcal meningitis treatment for Africa Trial of cryptococcal meningitis treatment in Malawi.","volume":"70","author":"Kanyama","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1056\/NEJMoa1710922","article-title":"Antifungal combinations for treatment of cryptococcal meningitis in Africa.","volume":"378","author":"Molloy","year":"2018","journal-title":"New Engl J Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1258\/ijsa.2011.010538","article-title":"Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients.","volume":"22","author":"Anekthananon","year":"2011","journal-title":"Int J STD AIDS."},{"key":"B28","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/cid\/cit794","article-title":"Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes.","volume":"58","author":"Jarvis","year":"2014","journal-title":"Clin Infect Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1093\/cid\/cix870","article-title":"Long-term mortality and disability in cryptococcal meningitis: a systematic literature review.","volume":"66","author":"Pasquier","year":"2018","journal-title":"Clin Infect Dis."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-7-47","article-title":"Sequelae due to bacterial meningitis among African children: a systematic literature review.","volume":"7","author":"Ramakrishnan","year":"2009","journal-title":"BMC Med."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25416","article-title":"Mortality from HIV-associated meningitis in sub-Saharan Africa: a systematic review and meta-analysis.","volume":"23","author":"Tenforde","year":"2020","journal-title":"J Int AIDS Soc."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ."},{"key":"B33","first-page":"p. 1","author":"Peterson","year":"2011","journal-title":"The Newcastle-Ottawa scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928","article-title":"The cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ."},{"key":"B35","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America.","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-020-04324-z","article-title":"Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial.","volume":"21","author":"Manyazewal","year":"2020","journal-title":"Trials."},{"key":"B37","doi-asserted-by":"publisher","first-page":"486","DOI":"10.4103\/1947-2714.117318","article-title":"Cryptococcal meningoencephalitis in human immunodeficiency virus\/acquired immunodeficiency syndrome in douala, cameroon: a cross sectional study.","volume":"5","author":"Luma","year":"2013","journal-title":"N Am J Med Sci."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250195","article-title":"High burden of cryptococcal antigenemia and meningitis among patients presenting at an emergency department in Maputo, Mozambique.","volume":"16","author":"Deiss","year":"2021","journal-title":"PLoS One."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofv046","article-title":"Cryptococcal antigenemia in immunocompromised HIV patients in rural Tanzania: a preventable cause of early mortality.","volume":"2","author":"Letang","year":"2015","journal-title":"Open Forum Infect Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/qjmed\/89.7.499","article-title":"The spectrum of meningitis in a population with high prevalence of HIV disease.","volume":"89","author":"Bergemann","year":"1996","journal-title":"QJM Int J Med."},{"key":"B41","first-page":"559","article-title":"Update on neuromeningeal cryptococcosis in Dakar.","volume":"65","author":"Soumare","year":"2005","journal-title":"Med Trop."},{"key":"B42","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.mycmed.2011.12.074","article-title":"Retrospective study of cases of neuromeningeal cryptococcosis at the University Hospital of Bobo Dioulasso since accessibility to antiretroviral in Burkina Faso.","volume":"22","author":"Bamba","year":"2012","journal-title":"J Mycol Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s13149-011-0139-3","article-title":"Opportunistic infections of the HIV\/AIDS in adults in hospital settings in Togo.","volume":"104","author":"Apetse","year":"2011","journal-title":"Bull Soc Pathol Exot."},{"key":"B44","first-page":"149","article-title":"Epidemiological, clinical and prognostic aspects of cryptococcal meningitis in hospital area of Bamako, Mali.","volume":"29","author":"Oumar","year":"2008","journal-title":"Rev Med Brux."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-4862-x","article-title":"Prevalence and mortality of cryptococcal disease in adults with advanced HIV in an urban tertiary hospital in Sierra Leone: a prospective study.","volume":"20","author":"Lakoh","year":"2020","journal-title":"BMC Infect Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1086\/649861","article-title":"Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi.","volume":"50","author":"Nussbaum","year":"2010","journal-title":"Clin Infect Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1086\/516372","article-title":"Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS.","volume":"26","author":"Kizza","year":"1998","journal-title":"Clin Infect Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1086\/593194","article-title":"Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda.","volume":"47","author":"Longley","year":"2008","journal-title":"Clin Infect Dis."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008630","article-title":"Treatment of cryptococcal meningitis in KwaZulu-Natal, South Africa.","volume":"5","author":"Lightowler","year":"2010","journal-title":"PLoS One."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0110285","article-title":"A prospective study of mortality from cryptococcal meningitis following treatment induction with 1200mg oral fluconazole in Blantyre, Malawi.","volume":"9","author":"Gaskell","year":"2014","journal-title":"PLoS One."},{"key":"B51","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1177\/0956462416653559","article-title":"Cryptococcal meningitis in a tertiary hospital in Pretoria, mortality and risk factors\u2013A retrospective cohort study.","volume":"28","author":"Hiesgen","year":"2017","journal-title":"Int J STD AIDS."},{"key":"B52","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1086\/604716","article-title":"Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients.","volume":"49","author":"Bicanic","year":"2009","journal-title":"Clin Infect Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/0974-2727.59702","article-title":"Diagnostic value of latex agglutination in cryptococcal meningitis.","volume":"1","author":"Dominic","year":"2009","journal-title":"J Lab Phys."},{"key":"B54","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s40475-015-0046-y","article-title":"Cryptococcal meningitis: diagnosis and management update.","volume":"2","author":"Abassi","year":"2015","journal-title":"Curr Trop Med Rep."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05129-w","article-title":"Cryptococcal antigenemia and its predictors among HIV infected patients in resource limited settings: a systematic review.","volume":"20","author":"Derbie","year":"2020","journal-title":"BMC Infect Dis."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S135309","article-title":"incidence, clinical presentation, and outcome of hiV-1-associated cryptococcal meningitis during the highly active antiretroviral therapy era: a nationwide cohort study.","volume":"9","author":"Touma","year":"2017","journal-title":"Clin Epidemiol."},{"key":"B57","first-page":"152","article-title":"Prognostic markers in AIDS-related cryptococcal meningitis.","volume":"59","author":"Majumder","year":"2011","journal-title":"J Assoc Phys India."},{"key":"B58","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS.","volume":"23","author":"Park","year":"2009","journal-title":"Aids."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1099\/jmm.0.46657-0","article-title":"Prevalence of cryptococcal meningitis at a tertiary care centre in Western India (1996 2005).","volume":"55","author":"Satpute","year":"2006","journal-title":"J Med Microbiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/14787210.2020.1785871","article-title":"Cryptococcal meningitis: a review of cryptococcal antigen screening programs in Africa.","volume":"19","author":"Greene","year":"2021","journal-title":"Expert Rev Anti Infect Ther."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-016-0179-9","article-title":"Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count.","volume":"5","author":"Bigna","year":"2016","journal-title":"Infect Dis Poverty."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1093\/cid\/ciw125","article-title":"Incidence of opportunistic infections and the impact of antiretroviral therapy among HIV-infected adults in low-and middle-income countries: a systematic review and meta-analysis.","volume":"62","author":"Low","year":"2016","journal-title":"Clin Infect Dis."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008823","article-title":"Determinants of two-year mortality among HIV positive patients with Cryptococcal meningitis initiating standard antifungal treatment with or without adjunctive dexamethasone in Uganda.","volume":"14","author":"Kitonsa","year":"2020","journal-title":"PLoS Negl Trop Dis."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz478","article-title":"Seizures in human immunodeficiency virus-associated Cryptococcal meningitis: predictors and outcomes.","volume":"6","author":"Pastick","year":"2019","journal-title":"Open Forum Infect Dis."},{"key":"B65","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.cmi.2016.04.022","article-title":"Cryptococcosis\u2014the impact of delay to diagnosis.","volume":"22","author":"Aye","year":"2016","journal-title":"Clin Microbiol Infect."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431X20176392","article-title":"Noninvasive intracranial pressure monitoring for HIV-associated cryptococcal meningitis.","volume":"50","author":"Bollela","year":"2017","journal-title":"Braz J Med Biol Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0002-9343(91)90126-I","article-title":"Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome.","volume":"91","author":"Denning","year":"1991","journal-title":"Am J Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/QAD.0b013e32832605fe","article-title":"Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures.","volume":"23","author":"Bicanic","year":"2009","journal-title":"Aids."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1016\/S1473-3099(18)30493-6","article-title":"Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries.","volume":"19","author":"Loyse","year":"2019","journal-title":"Lancet Infect Dis."},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofu052.1139","article-title":"1593 Predictors of Mortality for HIV-associated Cryptococcal Meningitis.","author":"Nimitvilai","year":"2014","journal-title":"Open Forum Infect Dis."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e2575","DOI":"10.1128\/mBio.02575-19","article-title":"Fluconazole monotherapy is a suboptimal option for initial treatment of cryptococcal meningitis because of emergence of resistance.","volume":"10","author":"Hope","year":"2019","journal-title":"MBio."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001318","article-title":"The challenges and possibilities of reducing deaths from cryptococcal meningitis in sub-Saharan Africa.","volume":"9","author":"Farlow","year":"2012","journal-title":"PLoS Med."},{"key":"B73","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1258\/ijsa.2011.010538","article-title":"Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patients.","volume":"22","author":"Team","year":"2011","journal-title":"Int J STD AIDS."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005223","article-title":"MLST-based population genetic analysis in a global context reveals clonality amongst Cryptococcus neoformans var. grubii VNI isolates from HIV patients in Southeastern Brazil.","volume":"11","author":"Ferreira-Paim","year":"2017","journal-title":"PLoS Negl Trop Dis."},{"key":"B75","article-title":"Predictors of Mortality for HIV-associated Cryptococcal Meningitis.","volume":"7","author":"Nimitvilai","year":"1908","journal-title":"Seizure."},{"key":"B76","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ijid.2017.08.004","article-title":"Outcomes of HIV-positive patients with cryptococcal meningitis in the Americas.","volume":"63","author":"Crabtree Ram\u00edrez","year":"2017","journal-title":"Int J Infect Dis."},{"key":"B77","article-title":"Mortality due to HIV-associated cryptococcal meningitis in Botswana in the ART era.","author":"Leeme","year":"2017","journal-title":"Proceedings of the Conference on Retroviruses and Opportunistic Infections (CROI)."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1093\/cid\/cit019","article-title":"Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis.","volume":"56","author":"Bisson","year":"2013","journal-title":"Clin Infect Dis."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.989265\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T11:29:50Z","timestamp":1662636590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.989265\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,8]]},"references-count":78,"alternative-id":["10.3389\/fmed.2022.989265"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.989265","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,8]]},"article-number":"989265"}}